Skip to main content

Table 1 Relationship of serum survivin with clinical staging

From: Early diagnostic value of survivin and its alternative splice variants in breast cancer

Survivin ELISA

Stage II/III

Stage IV

Moderate to high (70 pg/ml)

17 (94%)

19 (86%)

Low normal to mild (<50 pg/ml)

1 (6%)

3 (14%)

Total

18

22